ArticleTargeted oncology2024

Impact of AML1/ETO Fusion on the Efficacy of Venetoclax Plus Hypomethylating Agents in Newly Diagnosed Acute Myeloid Leukemia.

Dian Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.